Dr. Mark Bloomston

  • MD, FACS
  • Surgical Oncologist
  • Spoken languages English


Dr. Bloomston returned to his home town of Fort Myers in September 2015 after a distinguished academic career as Associate Professor, Surgical Oncology Fellowship director, and director of the GI Cancer Service Line at Ohio State University. He has authored nearly 200 articles and served on the NCI Neuroendocrine task force and the NCCN Hepatobiliary guidelines committee. His interests are in complex GI cancers and advanced surgical procedures, such as complex pancreas surgery, major liver surgery, biliary reconstruction, hepatic artery infusion pumps, and heated intraperitoneal chemotherapy (HIPEC). He is ranked in the top 10 percentile for patient satisfaction and is considered one of the nation’s top doctors by US News and World Report.

Career Positions

Current position(s)

  • Medical Director, South Florida Surgical Oncology, Fort Myers, FL,

Past position(s)

  • Medical Director, GI Cancer Service Line, Ohio State University, Columbus, OH
  • Associate Professor of Surgery with Tenure, Ohio State University, Columbus, OH
  • Graduate Faculty "M" Status, Masters of Science in Medical Science Program, Ohio State University, Columbus, OH
  • Director, Surgical Oncology Fellowship Program, Ohio State University, Columbus, OH
  • Assistant Professor of Surgery, Ohio State University, Columbus, OH



  • Florida State University, Bachelor of Science, Biology, Tallahassee, FL
  • University of South Florida, Medical Doctorate, Tampa, FL


  • University of South Florida, Research Fellow in Pancreatic Cancer, Tampa, FL
  • University of South Florida, General Surgery, Tampa, FL


  • University of South Florida, General Surgery, Tampa, FL


  • Ohio State University, Surgical Oncology Fellow, Columbus, OH


Awards and honors

  • Fellow, American College of SurgeonsOutstanding Achievement in Patient ServiceCastle Connolly Top Doctors (2012, 2013)US News and World Report Top Doctors (2012, 2013)American Registry Top 10 Oncologists in OhioSilver Resident Research Award, Resident Pre


  • Retraction: Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.
  • Survival after Hepatectomy for Metastatic Colorectal Cancer in the Presence of Resectable Extrahepatic Disease
  • The Management of Pancreas Divisum
  • Splenectomy in Hematologic Malignancies
  • Uncommon Cancers of the Thyroid
Expand Publications
View 3 more